Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Decreased by Gagnon Securities LLC

Gagnon Securities LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 4.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 59,161 shares of the medical equipment provider’s stock after selling 2,909 shares during the quarter. Intuitive Surgical makes up approximately 6.2% of Gagnon Securities LLC’s portfolio, making the stock its 2nd biggest holding. Gagnon Securities LLC’s holdings in Intuitive Surgical were worth $30,880,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the stock. Berbice Capital Management LLC purchased a new position in Intuitive Surgical in the fourth quarter worth $26,000. Godsey & Gibb Inc. grew its position in Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical in the third quarter worth $33,000. Decker Retirement Planning Inc. purchased a new position in Intuitive Surgical in the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP purchased a new position in Intuitive Surgical in the third quarter worth $38,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In related news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock valued at $15,357,560 over the last 90 days. Insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on ISRG shares. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a “buy” rating in a research report on Friday, January 24th. Raymond James upped their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a research note on Friday, January 24th. Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Finally, Mizuho upped their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $571.88 on Friday. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a 50 day moving average price of $549.92 and a 200-day moving average price of $508.00. The stock has a market capitalization of $203.69 billion, a PE ratio of 89.22, a PEG ratio of 5.52 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.